Home > Specialists > Pancreatic Surgery > Dr. Xiaowu Xu (徐晓武)
Home > Specialists > General Surgery > Dr. Xiaowu Xu (徐晓武)

Specialty & Clinical Focus:
Pancreatic surgery specialist at Fudan University Shanghai Cancer Center in Shanghai, with a clinical focus on robotic and laparoscopic surgery, function-preserving pancreatic procedures, pancreatic neuroendocrine tumors, and the surgical management of pancreatic and hepatobiliary malignancies.
Professional Title & Qualifications:
Chief Physician
Professor
Doctoral Supervisor (PhD Supervisor)
Deputy Director, Department of Pancreatic Surgery
Director, Center for Minimally Invasive Pancreatic Surgery
Hospital & Department:
Fudan University Shanghai Cancer Center – Department of Pancreatic Surgery
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Xiaowu Xu (徐晓武) - Pancreatic Surgeon
Personal Biography
Dr. Xiaowu Xu is a Chief Physician and Professor in the Department of Pancreatic Surgery at Fudan University Shanghai Cancer Center (FUSCC), where he serves as Deputy Director of the department and Director of the Center for Minimally Invasive Pancreatic Surgery. His clinical practice focuses on robotic and laparoscopic pancreatic surgery, including function-preserving procedures for benign and low-grade malignant pancreatic tumors. Trained under Professor Mou Yiping, Dr. Xu was an early practitioner of laparoscopic pancreatic and gastrointestinal surgery in China. Before joining FUSCC in 2018, he held senior surgical roles at Sir Run Run Shaw Hospital and Zhejiang Provincial People's Hospital. He leads a team that performs more than 800 pancreatic operations annually, with over 80% performed using minimally invasive techniques.
Why Choose Dr. Xiaowu Xu for Your Pancreatic Care?
Dr. Xiaowu Xu directs the Center for Minimally Invasive Pancreatic Surgery at Fudan University Shanghai Cancer Center and leads a high-volume team with extensive experience in robotic, laparoscopic, and function-preserving pancreatic procedures. His clinical focus is particularly relevant to patients seeking specialist input on pancreatic tumors, pancreatic neuroendocrine tumors, or complex hepatobiliary and pancreatic surgery. For international patients, a structured remote specialist review can help organize imaging, pathology, previous treatment records, and key questions before deciding whether to pursue care in Shanghai.
Pre-Travel Case Review & Specialist Liaison
Before committing to medical travel, international patients can request MedBridgeNZ coordination for a remote specialist review with Dr. Xiaowu Xu. We prepare and organize medical records, coordinate translation, arrange secure client-authorized document transfer, and manage appointment communication with the relevant hospital team.
Once the hospital confirms and schedules the review, Dr. Xu or the relevant specialist team will review the submitted records, provide an independent clinical opinion and recommendations, and address the patient’s submitted questions. This pre-travel pathway can help clarify the proposed next steps and support practical planning for a possible hospital visit in Shanghai.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Xiaowu Xu
Areas of Expertise
Minimally Invasive Surgery: Proficient in robotic and laparoscopic surgeries for various benign and malignant tumors of the pancreas, liver, gallbladder, spleen, and gastrointestinal stromal tumors (GISTs).
Function-Preserving Pancreatic Surgery: Specializes in complex procedures such as robotic/laparoscopic enucleation of pancreatic tumors, duodenum-preserving pancreatic head resection (DPPHR), central pancreatectomy, and spleen-preserving distal pancreatectomy (Warshaw and Kimura techniques).
Comprehensive Treatment: Expertise in multidisciplinary and comprehensive surgical treatment and adjuvant chemotherapy for pancreatic and hepatobiliary malignancies.
Neuroendocrine Tumors: Surgical management of pancreatic neuroendocrine tumors.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
5,600 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
2018–Present: Deputy Director, Department of Pancreatic Surgery; Director, Center for Minimally Invasive Pancreatic Surgery, Fudan University Shanghai Cancer Center (Shanghai, China).
Previous: Deputy Director, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital.
Previous: Associate Chief Physician, Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine.
Education & Training
Studied under Professor Mou Yiping, an expert in minimally invasive surgery in China.
Awards & Honors
First Prize, The 1st National Robotic Surgery Competition.
Second Prize, Zhejiang Province Science and Technology Progress Award (ranked second as a major contributor).
“Annual Good Doctor” Award, received in 2022, 2023, and 2024 (HaoDF).
Academic & Professional Memberships
Standing Committee Member, Pancreatic Cancer Professional Committee, China Anti-Cancer Association (CACA).
Member, Minimally Invasive Diagnosis and Treatment Group, Pancreatic Cancer Professional Committee, CACA.
Member, Neuroendocrine Tumor Professional Committee, CACA.
Young Committee Member, General Surgery Branch, Shanghai Medical Association.
Member, Minimally Invasive Surgery Group, General Surgery Branch, Shanghai Medical Association.
Deputy Leader, Multi-regional Diagnosis and Treatment Collaboration Young Group, Pancreatic Cancer Professional Committee, Shanghai Anti-Cancer Association.
Research & Publications
Principal Investigator: Led 3 projects funded by the National Natural Science Foundation of China.
Publications: Published over 20 academic papers in SCI-indexed journals as the first author or corresponding author.
Research Focus: Clinical research on robotic and laparoscopic minimally invasive surgery for well-differentiated pancreatic neuroendocrine tumors, and basic translational research related to pancreatic malignancies.
Selected Peer-Reviewed Publications
Li Z, Xu X, et al. Main pancreatic duct exposure, repair, or reconstruction during minimally invasive pancreatic enucleation: a long-term metabolic outcome from a prospective cohort study (CSPAC-MIEN-1). Int J Surg. 2025;111(11):8001–8014. PMID: 40679988.
Liu C, Xu X, et al. Effect of laparoscopic versus open distal pancreatectomy on recurrence-free survival in patients with left-sided pancreatic cancer: a randomized controlled trial. Ann Surg. 2025;282(6):930–938. PMID: 39996303.
Zhang WH, Xu X, et al. The surgical and therapeutic activities of non-functional pancreatic neuroendocrine tumors at a high-volume institution. Cancers (Basel). 2023;15(7):1955. PMID: 37046616.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Xu’s expertise relevant to my specific pancreatic condition?
Dr. Xu’s clinical focus includes robotic and laparoscopic surgery for benign and malignant pancreatic tumors, function-preserving procedures for benign and low-grade malignant pancreatic lesions, pancreatic neuroendocrine tumors, and the broader surgical management of pancreatic and hepatobiliary malignancies. Once a remote specialist-review request is accepted and scheduled, MedBridgeNZ coordinates record preparation, translation, and client-authorized transfer to the hospital. Dr. Xu or the relevant specialist team will review the submitted records and provide an independent opinion on the case, possible next steps, and the patient’s submitted questions.
How can an international patient request a remote review or hospital appointment with Dr. Xu?
International patients can submit a request through MedBridgeNZ for remote specialist-review coordination or an in-person appointment at Fudan University Shanghai Cancer Center. We help organize the medical summary, imaging, pathology reports, previous treatment information, and other available records, coordinate translation, and communicate the request to the hospital. Once the hospital accepts and schedules the review, the specialist will examine the materials and respond to the submitted clinical questions. Any subsequent onsite appointment is coordinated according to the hospital’s scheduling process and availability.
What support is available if I travel to Shanghai for pancreatic care?
If the specialist’s opinion supports considering an in-person hospital pathway, MedBridgeNZ can coordinate the non-clinical preparation for travel to Shanghai. Support can include hospital appointment communication, medical invitation or visa-document coordination, travel and accommodation planning, translation coordination, and bilingual administrative assistance during hospital visits. These services are organized around the hospital’s confirmed schedule so that the patient has a clearer itinerary, document plan, and communication pathway before departure.
How are language barriers handled during the remote review and hospital visit?
MedBridgeNZ coordinates professional translation of the patient’s existing medical records before they are submitted for Dr. Xu’s review. We also help prepare a bilingual question list and coordinate communication concerning appointment instructions and required documentation. For in-person visits, non-clinical bilingual administrative support can be arranged to assist with registration, hospital navigation, and communication logistics. Medical opinions, recommendations, and treatment decisions are provided by the licensed specialist or hospital team.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document support, travel planning, and non-clinical bilingual administrative support for a more organized medical travel process. MedBridgeNZ does not provide medical advice, diagnosis or treatment. Hospital, specialist and other third-party medical or travel costs are separate from MedBridgeNZ coordination fees unless expressly stated otherwise in writing.
